|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/00 | |
| A61K 31/711 | |||
| A61P 27/02 |
| (11) | Patento numeris | 2086503 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07868629.2 |
| Europos patento paraiškos padavimo data | 2007-10-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-08-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-12-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2007/083103 |
| Data | 2007-10-31 |
| (87) | Numeris | WO 2008/057867 |
| Data | 2008-05-15 |
| (30) | Numeris | Data | Šalis |
| 556503 | 2006-11-03 | US |
| (72) |
TROGDEN, John T., US
LYONS, Robert T., US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | SUSTAINED RELEASE DRUG DELIVERY SYSTEMS COMPRISING A WATER SOLUBLE THERAPEUTIC AGENT AND A RELEASE MODIFIER |
| SUSTAINED RELEASE DRUG DELIVERY SYSTEMS COMPRISING A WATER SOLUBLE THERAPEUTIC AGENT AND A RELEASE MODIFIER |